Zurueck zur Suche

Reporte zur Charge UT7376MA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 6 FL 2

VAERS 1992468

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

schwer
Staat
TX
Alter
19,0
Geschlecht
F
Eingang
30.12.2021
Impfdatum
30.12.2021
Beginn
30.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Condition aggravated Fatigue Loss of consciousness Pallor

Symptomtext

RN gave booster Moderna in R deltoid and Influenza in L deltoid. Patient got up and walked to a chair with parents. She told her parents after a couple of minutes that she felt tired and soon after she passed out. RN saw something taking place. Got pulse ox, ice pack and BP cuff. Patient was arousing when nurse got to her. Put ice pack to neck. Pulse was 66 O2 sat 99% and BP was 88/50. Family later states she has passes out twice before. once when her dogs tale was cut off and another time when her ear was pierce with a needle. Patient place in recovery position. Face was pale she was clamy. Color soon returned after being put in recovery position. She was alert and oriented. She carried on a conversation. 12:20 vitals pulse 80 O2sat 99% 12:24 BP 98/60. Has her sit up after a time. Give sucker and some water. 12:49 before getting her in a wheelchair to leave BP 100/67, Pulse 75 O2sat 98%. Parent state his father is a doctor, They will contact him. She stated she was feeling fine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none known
Vorherige Impfungen
-

VAERS 1782940

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

moderat
Staat
TX
Alter
52,0
Geschlecht
F
Eingang
13.10.2021
Impfdatum
06.10.2021
Beginn
06.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anxiety Blood potassium decreased Dysphagia Full blood count Hypoaesthesia Paraesthesia

Symptomtext

numbness in head 1 hour after vax, couldnt swallow, numbness throughout whole body, high anxiety

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
went to ER and had cbcs, chemistry done potassium was low er said she had paresthesia
Aktuelle Erkrankungen
-
Vorgeschichte
anemia
Andere Medikamente
Ferrous sulfate melatonin calcium d3 20
Allergien
-
Vorherige Impfungen
-

VAERS 2485575

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

gering
Staat
TX
Alter
45,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
19.10.2022
Beginn
19.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

Error in administration; Expired vaccine; No adverse reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485569

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

gering
Staat
TX
Alter
34,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
19.10.2022
Beginn
19.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Error in administration; Expired vaccine; No adverse reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485555

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

gering
Staat
TX
Alter
28,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
19.10.2022
Beginn
19.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Error in administration; Expired vaccine; No adverse reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2485549

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

gering
Staat
TX
Alter
45,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
19.10.2022
Beginn
19.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Error in administration; Expired vaccine; No adverse reactions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1970870

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
22.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error Wrong technique in product usage process

Symptomtext

two patients were administered "non-viable" FLUZONE QUADRIVALENT with no reported adverse event; Initial information received on 09-Dec-2021 regarding an unsolicited valid non-serious case from a Pharmacist via Media information (under the reference 00872588). This case is linked to case 2021SA415946(CLUSTER). This case involves two patients who received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (poor quality product administered). The patients' medical history, past medical treatment, vaccination, concomitant medication and family history were not provided. On 08-Dec-2021, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7376MA and expiry date: 30-Jun-2022) via intramuscular route in unknown administration site for prophylactic vaccination. It was an actual medication error due to Wrong technique in product usage process (latency: same day). It was reported pharmacist called to report that two patients were administered "non-viable" FLUZONE QUADRIVALENT today 08Dec2021. Pharmacist reports that they received a shipment of (12) FLUZONE QUADRIVALENT today. Pharmacist reports that two (2) patients received the FLUZONE QUAD vaccine today from that shipment. Reporter stated that RPh reports that it was discovered later in the day that the packing slip says the package was in transit since September. RPh reports the product was cold upon receipt so no one noticed the packing slip date. RPH spoke with and was advised that vaccines were non viable since the packaging slip reports that it was in transit since Sept 20, 2021. Pharmacy also received (11) boxes of FLUZONE HD in that same package. No patients received the FLUZONE HD vaccine. (12) FLUZONE QUAD with LOT# UT7376MA EXP: 6/30/2022 (11) FLUZONE HD with LOT# UJ7S0AC EXP: 6/30/2022 RPh is inquiring about re-vaccination for these patients At the time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1970869

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7376MA

gering
Staat
FL
Alter
56,0
Geschlecht
M
Eingang
22.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error Product storage error

Symptomtext

A patient received a non-viable FLUZONE QUADRIVALENT from shipment no AE; Initial information regarding an unsolicited valid non-serious case was received from a pharmacist via Medical Information (MI) (Reference number- 00890492) and transmitted to Sanofi on 08-Dec-2021. This case is linked to case 2021SA415315 (Same reporter). This case involves a 56 year old male patient who was received non-viable INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] on 08-Dec-2021 from shipment which was in transit since Sept 20, 2021 (Product storage error). The patient's medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 08-Dec-2021, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7376MA, expiry: 30-Jun-2022) via intramuscular route in the left deltoid for prophylactic vaccination. It was a case of an actual medication error due to Incorrect product storage (latency same day). It was reported "Pharmacist called to report that two patients were administered "non-viable" FLUZONE QUADRIVALENT today 08Dec2021. Pharmacist reports that they received a shipment of (12) FLUZONE QUADRIVALENT today. Pharmacist reports that two (2) patients received the FLUZONE QUAD vaccine today from that shipment. RPh reports that it was discovered later in the day that the packing slip says the package was in transit since September. Registered Pharmacist (RPh) reports the product was cold upon receipt so no one noticed the packing slip date. RPH spoke with and was advised that vaccines were non viable since the packaging slip reports that it was in transit since Sept 20, 2021. Pharmacy also received (11) boxes of FLUZONE HD in that same package. No patients received the FLUZONE HD vaccine. RPh is inquiring about re-vaccination for these patients and how soon?" No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-